Filed: 5/15/2024ACC: 0001214659-24-009296
📋 What this filing means
CUTTER CAPITAL MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 25 equity positions with a total reported market value of $259.35M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
25
Positions
$259.35M
Total AUM (reported)
8.80M
Total Shares
Allocation by class
COM$185.02M71.3%
SPONSORED ADS$20.50M7.9%
SHS$19.52M7.5%
SHS CLASS A$12.50M4.8%
NAMEN AKT$8.19M3.2%
COMMON STOCK$7.44M2.9%
COM PAR $.01$6.17M2.4%
Portfolio Concentration
Top 3$59.70M23.0%
4–10$91.68M35.3%
11–25$107.96M41.6%
Top 3 weight
23.0%
Top 10 weight
58.4%
Voting Authority Distribution
Total shares with voting rights: 8.80M
Sole
Full voting authority
8.80M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole25
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings25
Rows:
BRISTOL-MYERS SQUIBB CO
SOLEShares446.90K
TypeSH
Market value$24.24M
9.34%
Sole
446.90K
Shared
0.00
None
0.00
GILEAD SCIENCES INC
SOLEShares265.44K
TypeSH
Market value$19.44M
7.50%
Sole
265.44K
Shared
0.00
None
0.00
TEVA PHARMACEUTICAL INDS LTD
SOLEShares1.14M
TypeSH
Market value$16.02M
6.18%
Sole
1.14M
Shared
0.00
None
0.00
REGENERON PHARMACEUTICALS
SOLEShares16.36K
TypeSH
Market value$15.75M
6.07%
Sole
16.36K
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares175K
TypeSH
Market value$15.28M
5.89%
Sole
175K
Shared
0.00
None
0.00
IONIS PHARMACEUTICALS INC
SOLEShares289.37K
TypeSH
Market value$12.54M
4.84%
Sole
289.37K
Shared
0.00
None
0.00
ROYALTY PHARMA PLC
SOLEShares411.54K
TypeSH
Market value$12.50M
4.82%
Sole
411.54K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares94.38K
TypeSH
Market value$12.22M
4.71%
Sole
94.38K
Shared
0.00
None
0.00
ACADIA PHARMACEUTICALS INC
SOLEShares658.41K
TypeSH
Market value$12.17M
4.69%
Sole
658.41K
Shared
0.00
None
0.00
BIOGEN INC
SOLEShares52K
TypeSH
Market value$11.21M
4.32%
Sole
52K
Shared
0.00
None
0.00
BIOCRYST PHARMACEUTICALS INC
SOLEShares2.11M
TypeSH
Market value$10.70M
4.12%
Sole
2.11M
Shared
0.00
None
0.00
HALOZYME THERAPEUTICS INC
SOLEShares255.05K
TypeSH
Market value$10.38M
4.00%
Sole
255.05K
Shared
0.00
None
0.00
PERRIGO CO PLC
SOLEShares322.11K
TypeSH
Market value$10.37M
4.00%
Sole
322.11K
Shared
0.00
None
0.00
EXELIXIS INC
SOLEShares398.76K
TypeSH
Market value$9.46M
3.65%
Sole
398.76K
Shared
0.00
None
0.00
AVADEL PHARMACEUTICALS PLC
SOLEShares541.93K
TypeSH
Market value$9.15M
3.53%
Sole
541.93K
Shared
0.00
None
0.00
ELI LILLY & CO
SOLEShares11.04K
TypeSH
Market value$8.59M
3.31%
Sole
11.04K
Shared
0.00
None
0.00
AGIOS PHARMACEUTICALS INC
SOLEShares288.58K
TypeSH
Market value$8.44M
3.25%
Sole
288.58K
Shared
0.00
None
0.00
CRISPR THERAPEUTICS AG
SOLEShares120.19K
TypeSH
Market value$8.19M
3.16%
Sole
120.19K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares107K
TypeSH
Market value$7.44M
2.87%
Sole
107K
Shared
0.00
None
0.00
INSMED INC
SOLEShares227.34K
TypeSH
Market value$6.17M
2.38%
Sole
227.34K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares278.64K
TypeSH
Market value$4.88M
1.88%
Sole
278.64K
Shared
0.00
None
0.00
LEGEND BIOTECH CORP
SOLEShares79.83K
TypeSH
Market value$4.48M
1.73%
Sole
79.83K
Shared
0.00
None
0.00
KYVERNA THERAPEUTICS INC
SOLEShares166.51K
TypeSH
Market value$4.14M
1.59%
Sole
166.51K
Shared
0.00
None
0.00
PLIANT THERAPEUTICS INC
SOLEShares194.12K
TypeSH
Market value$2.89M
1.12%
Sole
194.12K
Shared
0.00
None
0.00
CABALETTA BIO INC
SOLEShares157.96K
TypeSH
Market value$2.69M
1.04%
Sole
157.96K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BRISTOL-MYERS SQUIBB COSOLE | COM | 446.90K | SH | $24.24M 9.34% | 446.90K | 0.00 | 0.00 |
GILEAD SCIENCES INCSOLE | COM | 265.44K | SH | $19.44M 7.50% | 265.44K | 0.00 | 0.00 |
TEVA PHARMACEUTICAL INDS LTDSOLE | SPONSORED ADS | 1.14M | SH | $16.02M 6.18% | 1.14M | 0.00 | 0.00 |
REGENERON PHARMACEUTICALSSOLE | COM | 16.36K | SH | $15.75M 6.07% | 16.36K | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 175K | SH | $15.28M 5.89% | 175K | 0.00 | 0.00 |
IONIS PHARMACEUTICALS INCSOLE | COM | 289.37K | SH | $12.54M 4.84% | 289.37K | 0.00 | 0.00 |
ROYALTY PHARMA PLCSOLE | SHS CLASS A | 411.54K | SH | $12.50M 4.82% | 411.54K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 94.38K | SH | $12.22M 4.71% | 94.38K | 0.00 | 0.00 |
ACADIA PHARMACEUTICALS INCSOLE | COM | 658.41K | SH | $12.17M 4.69% | 658.41K | 0.00 | 0.00 |
BIOGEN INCSOLE | COM | 52K | SH | $11.21M 4.32% | 52K | 0.00 | 0.00 |
BIOCRYST PHARMACEUTICALS INCSOLE | COM | 2.11M | SH | $10.70M 4.12% | 2.11M | 0.00 | 0.00 |
HALOZYME THERAPEUTICS INCSOLE | COM | 255.05K | SH | $10.38M 4.00% | 255.05K | 0.00 | 0.00 |
PERRIGO CO PLCSOLE | SHS | 322.11K | SH | $10.37M 4.00% | 322.11K | 0.00 | 0.00 |
EXELIXIS INCSOLE | COM | 398.76K | SH | $9.46M 3.65% | 398.76K | 0.00 | 0.00 |
AVADEL PHARMACEUTICALS PLCSOLE | SHS | 541.93K | SH | $9.15M 3.53% | 541.93K | 0.00 | 0.00 |
ELI LILLY & COSOLE | COM | 11.04K | SH | $8.59M 3.31% | 11.04K | 0.00 | 0.00 |
AGIOS PHARMACEUTICALS INCSOLE | COM | 288.58K | SH | $8.44M 3.25% | 288.58K | 0.00 | 0.00 |
CRISPR THERAPEUTICS AGSOLE | NAMEN AKT | 120.19K | SH | $8.19M 3.16% | 120.19K | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 107K | SH | $7.44M 2.87% | 107K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 227.34K | SH | $6.17M 2.38% | 227.34K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 278.64K | SH | $4.88M 1.88% | 278.64K | 0.00 | 0.00 |
LEGEND BIOTECH CORPSOLE | SPONSORED ADS | 79.83K | SH | $4.48M 1.73% | 79.83K | 0.00 | 0.00 |
KYVERNA THERAPEUTICS INCSOLE | COM | 166.51K | SH | $4.14M 1.59% | 166.51K | 0.00 | 0.00 |
PLIANT THERAPEUTICS INCSOLE | COM | 194.12K | SH | $2.89M 1.12% | 194.12K | 0.00 | 0.00 |
CABALETTA BIO INCSOLE | COM | 157.96K | SH | $2.69M 1.04% | 157.96K | 0.00 | 0.00 |